Slingshot members are tracking this event:
Alnylam (ALNY) Expects to Initiate Phase 3 Trial in Late 2017 Study Evaluating Givosiran (ALN-AS1) for the Treatment of Acute Hepatic Porphyrias
Slingshot Insights Explained
Sep 07, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Aln-as1, Phase 1 Study Results, Initiation, Phase 3 Trial, Givosiran